The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JEM
Citing Articles
Right arrow Citing Articles via CrossRef

Index of Online Supplemental Material for
J. Exp. Med. 10.1084/jem.20071397
Hirota et al.

Figure S1 Gene microarray analysis of IL-17high versus IL-17low CD4+ T cells.

Figure S2 The expression of CCR6 on BALB/c or SKG CD4+ T cells and the induction of CCR6 on CD4+ T cells after homeostatic proliferation.

Figure S3 The expression of IL-1R1 on Th17 cells

Figure S4 CCR6+CD4+ T cells include not only IL-17–producing cells but also TNF-α–producing cells and Foxp3+ cells.

Figure S5 Anti-CCR6 mAb is not cell depleting.

Figure S6 Anti-CCR6 antibody treatment inhibits the migration of CCR6+CD4+ cells into the joints.

Figure S7 The expression of CCR6 on human Th17 cells.





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JEM
Citing Articles
Right arrow Citing Articles via CrossRef


  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS